🇪🇺 [89Zr]Zr-crefmirlimab berdoxam in European Union

[89Zr]Zr-crefmirlimab berdoxam (89zr-zr-crefmirlimab-berdoxam) regulatory status in European Union.

Marketing authorisation

EMA

  • Status: approved

[89Zr]Zr-crefmirlimab berdoxam in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in European Union

Frequently asked questions

Is [89Zr]Zr-crefmirlimab berdoxam approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for [89Zr]Zr-crefmirlimab berdoxam in European Union?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.